Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vera Therapeutics Q3 EPS $(0.91) Down From $(0.36) YoY

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ardelyx Earlier Provided Update On 2024 Strategic Priorities; Expects FY24 U.S. Net Product Sales Revenue For IBSRELA To Be Between $140M-$150M; As Of December 31, 2023, The Co Had Total Cash, Cash Equivalents And Short-Term Investments Of ~$184M

By Benzinga Newsdesk
January 8, 12:01 PM
Company achieved significant commercial progress in 2023 IBSRELA® now expected to generate greater than $1.0 billion in annual U.S. net product sales revenue at peakWebcast scheduled for 7:00 PM ET / 4:00 PM PT

ARDX